"From high quality medical services to nationally renowned medical education and residency programs, Methodist Dallas Medical Center is a leading healthcare resource in North Texas. Our hospital features private rooms, 585 beds, and more than 250 highly skilled physicians. Time and again we have been recognized for our high standards of care for heart attack, heart failure, pneumonia, stroke, and other medical issues that require expert-level treatment."

During the past decade, Methodist Dallas Medical Center conducted 77 clinical trials. In the 10-year time frame, 77 clinical trials started and 16 clinical trials were completed, i.e. on average, 20.8% percent of trials that started reached the finish line to date. In the past 5 years, 49 clinical trials started and 12 clinical trials were completed. i.e. 24.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Methodist Dallas Medical Center" #1 sponsor was "Methodist Health System" with 55 trials, followed by "Boston Scientific Corporation" with 4 trials sponsored, "Gilead Sciences" with 2 trials sponsored, "Medical University of South Carolina" with 2 trials sponsored and "American Gastroenterological Association" with 2 trials sponsored. Other sponsors include 21 different institutions and companies that sponsored additional 31 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Methodist Dallas Medical Center" #1 collaborator was "Beth Israel Deaconess Medical Center" with 2 trials as a collaborator, "National Cancer Institute (NCI)" with 2 trials as a collaborator, "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)" with 2 trials as a collaborator, "National Institute on Aging (NIA)" with 2 trials as a collaborator and "University of Michigan" with 2 trials as a collaborator. Other collaborators include 39 different institutions and companies that were collaborators in the rest 49 trials.

According to Clinical.Site data, the most researched conditions in "Methodist Dallas Medical Center" are "COVID-19" (3 trials), "Alcoholic Hepatitis" (2 trials), "Breast Cancer" (2 trials), "Cholangiocarcinoma" (2 trials) and "Cirrhosis" (2 trials). Many other conditions were trialed in "Methodist Dallas Medical Center" in a lesser frequency.

Most popular intervention types in "Methodist Dallas Medical Center" are "Drug" (20 trials), "Procedure" (20 trials), "Other" (19 trials), "Device" (9 trials) and "Biological" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Observational" (3 trials), "ADE-RED scoring tool" (1 trials), "Alteplase 50 MG [Activase]" (1 trials) and "AneuRx AAA stent graft / Talent AAA stent graft" (1 trials). Other intervention names were less common.

The vast majority of trials in "Methodist Dallas Medical Center" are 80 trials for "All" genders, 5 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Methodist Dallas Medical Center". undefined are not yet recruiting, 19 are recruiting, 2 are Active, not recruiting, and 19 are Enrolling by invitation. In total, there were 38 completed trials in Methodist Dallas Medical Center, undefined suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Methodist Dallas Medical Center, 1 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 10 trials that are defined as “Not Applicable".

Methodist Dallas Medical Center has several departments that took part in Clinical trials: "Neurology Associates of Arlington, P.A." - 6 trials, "Methodist Dallas Medical Center Pharmacy" - 2 trials